Related Experiment Video
Updated: Jun 13, 2025
Observing Islet Function and Islet-Immune Cell Interactions in Live Pancreatic Tissue Slices
Published on: April 12, 2021
RNA editing deficiency models differential immunogenicity of pancreatic α- and β-cells
Shani Peleg1, Liza Zamashanski1, Jonathan Belin1
1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Objective:
A longstanding question in type 1 diabetes (T1D) research pertains to the selective loss of β-cells whilst neighboring islet α-cells remain unharmed. We examined molecular mechanisms that may underly this differential vulnerability, by investigating the role of RNA editing, a cellular process that prevents double-stranded RNA (dsRNA)-mediated interferon response, in mouse α- and β-cells.
Methods:
The enzyme responsible for RNA editing, Adar, was selectively deleted in vivo in mouse β-cells, α-cells, or in both cell types. Subsequent analyses were performed to investigate the impact of deficient RNA editing in α- or β-cells on the interferon response, islet inflammation, cell viability and metabolic outcomes.
Results:
Mosaic disruption of the Adar gene in mouse β-cells triggers a massive interferon response, islet inflammation and mutant β-cell destruction. Surprisingly, wild type β-cells are also eliminated, whereas neighboring α-cells are unaffected. α-cell Adar deletion leads to only a slight elevation in interferon signature and does not elicit inflammation nor a metabolic phenotype. Concomitant deletion of Adar in α- and β-cells leads to elimination of both cell populations, suggesting that in contrast to β-cells, α-cell death requires both cell autonomous deficiency in RNA editing and exogenous cytokines.
Conclusions:
We demonstrate differential sensitivity of mouse α- and β-cells to deficient RNA editing. The resistance of α-cells to RNA editing deficiency and to cytokines mirrors their persistence in T1D, and constitutes a molecularly defined model of differential islet cell vulnerability.
Insights
Type 1 diabetes research reveals that impaired RNA editing selectively destroys mouse beta-cells, not alpha-cells. This differential vulnerability explains why alpha-cells survive in type 1 diabetes, offering a new model for the disease.
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Type 1 diabetes (T1D) is characterized by selective destruction of insulin-producing beta-cells, while glucagon-producing alpha-cells remain intact.
- The precise mechanisms underlying this differential cell vulnerability in the pancreatic islets are not fully understood.
Purpose of the Study:
- To investigate the role of RNA editing in differential islet cell survival and its link to type 1 diabetes pathogenesis.
- To elucidate the molecular basis for alpha-cell resistance to interferon-mediated inflammation.
Main Methods:
- Utilized mouse models with mosaic disruption of the Adar gene (RNA editing enzyme) in beta-cells and alpha-cells.
- Assessed interferon response, islet inflammation, cell destruction, and metabolic phenotypes.
- Analyzed the impact of Adar deficiency alone and in combination with exogenous cytokines.
Main Results:
- Deficient RNA editing in beta-cells triggered a strong interferon response, inflammation, and beta-cell destruction, also affecting wild-type beta-cells.
- Adar deletion in alpha-cells caused minimal interferon signature elevation, inflammation, or metabolic changes.
- Simultaneous Adar deletion in both cell types led to the elimination of both, indicating alpha-cell death requires additional cytokine signaling.
Conclusions:
- Mouse alpha-cells exhibit resistance to RNA editing deficiency and interferon responses, mirroring their persistence in T1D.
- This differential vulnerability provides a molecularly defined model for understanding islet cell behavior in type 1 diabetes.
- RNA editing deficiency is a critical factor in beta-cell loss, while alpha-cell survival depends on both intrinsic RNA editing and extrinsic inflammatory signals.
Related Concept Videos
02:23RNA Editing
01:25Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
01:40Cell-mediated Immune Responses
01:38Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...